Michael J. Schell

9.8k citations
168 papers · 7.8k · 2 hit papers · h-index 49

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Colorectal Cancer Treatments and Studies 11
    • Lung Cancer Research Studies 10
    • Cancer Immunotherapy and Biomarkers 7
    • Global Cancer Incidence and Screening 6
    • Lung Cancer Treatments and Mutations 19

Michael J. Schell

162 papers receiving 7.5k citations

Michael J. Schell's Hit Papers

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer 2020 · 351 citations
3510+3+6Years since publication100200300

Peers

Michael J. Schell
Comparison fields: 5 of 157
  • Oncology 2.8k
  • Pulmonary and Respiratory Medicine 1.7k
  • Cancer Research 706
  • Otorhinolaryngology 147
  • Pathology and Forensic Medicine 610
Replace Ateeq Ur Rehman Ghafoor with:
Ateeq Ur Rehman Ghafoor Pakistan
Marie‐Josèphe Horner United States
Alicia Samuels United States
Robert T. Greenlee United States
Taylor Murray United States
Urania G. Dafni Greece
Lucinda Jane Billingham United Kingdom
Karl‐Walter Jauch Germany
Isabella Sperduti Italy
Muhammad Wasif Saif United States
Michael J. Schell relative to Ateeq Ur Rehman Ghafoor Pakistan Ateeq Ur Rehman Ghafoor's profile →
Citations per field
00.5×5×10×15×20×22.5×
Ateeq Ur Rehman Ghafoor · 1×
Citations per year

Countries citing papers authored by Michael J. Schell

Since Specialization
Citations

This map shows the geographic impact of Michael J. Schell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Schell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Schell more than expected).

Fields of papers citing papers by Michael J. Schell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Schell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Schell. The network helps show where Michael J. Schell may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. Schell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Schell Line = papers co-authored together Michael J. Schell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 168 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
Hit paper breakdown →
2016371
2
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
Hit paper breakdown →
2020351
3 1987327
4 2008267
5 2001229
6 2014226
7 2016225
8 2016171
9 2010164
10 2002163
11 2006163
12 1995162
13 2016152
14 2009148
15 2001144
16 2019135
17 2012130
18 2013126
19 2003114
20 2015114

About Michael J. Schell

Michael J. Schell is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Statistics and Probability and Cancer Research, having authored 168 papers that have together received 7.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Research Studies (10 papers), Head and Neck Cancer Studies (9 papers), Statistical Methods in Clinical Trials (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Global Cancer Incidence and Screening (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Oncology (2.8k citations), Pulmonary and Respiratory Medicine (1.7k citations), Cancer Research (706 citations), Otorhinolaryngology (147 citations) and Pathology and Forensic Medicine (610 citations). Michael J. Schell has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Gerold Bepler, Mark A. Socinski, Tawee Tanvetyanon, Lennie Lott, Walter T. Hughes, Gaston K. Rivera, Eric B. Haura, Richard D. Kim, Ji‐Hyun Lee and Timothy Joseph Yeatman. Their work appears in journals such as Cancer, Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact